. 2023 Dec 13;204(1):171–179. doi: 10.1007/s10549-023-07176-8

Table 1.

Indication for genetic testing and cancer history in patients with CHEK2-associated invasive breast cancer

Indication for genetic testing
After initial cancer diagnosis	29/35 (83%)
Family member with CHEK2	4/35 (11%)
Strong family history/desired testing	1/35 (3%)
WISDOM trial ^a	1/35 (3%)
Family history of breast cancer^b	27/34 (79%)
Family history of breast cancer in 1st degree relative^ab	14/34 (41%)
Personal cancer history	6/35 (17%)

^aWomen Informed to Screen Depending on Measures of Risk Trial ^b One patient was adopted